Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Elagolix vs COCP in Symptomatic Endometrioma
NCT07763847Completed
- Start
- Apr 2025
- Primary completion
- Apr 2026
- Countries
- 1
01
Overview
Randomised, open-label trial of elagolix in endometrioma (2 arms). Primary endpoints: Change in size of endometrioma (mean diameter) at 3 months and Change in Pain score at 3 months. Started Apr 2025; status: completed.
02
Drugs
elagolix
03
Conditions
endometrioma
Beyond the preview
Go deeper on NCT07763847.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07763847.